Form4insider filings, from the source

SEC Form 4 · accession 0000899243-15-003613

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mary Z. Luo
Officer — COO and Chief Scientist · Director · 10% Owner
Jack Y. Zhang
Officer — CEO & Chief Scientific Officer · Director · 10% Owner
Period of report
Aug 17, 2015
Accepted (ET)
Aug 19, 2015 · 8:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 17, 2015M8,481$12.97A920,117D
Common StockF1Aug 17, 2015M8,481$12.97A670,147ISee footnote
Common StockF2holding———7,631,594ISee footnote
Common StockF3holding———5,000ISee footnote
Common StockF4holding———200,000ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F5$12.97Aug 17, 2015M8,481D—Sep 28, 2015Common Stock8,4810D
Employee Stock Option (right to buy)F1,F5$12.97Aug 17, 2015M8,481D—Sep 28, 2015Common Stock8,4810I

Explanation of responses